English | Español
Press release submission | Jul 1, 2019

EXPERIMENTAL BIOLOGY AND MEDICINE: A New Target for the Treatment of Idiopathic Pulmonary Fibrosis
Press release submission | Jun 28, 2019

AJ VACCINES: Will Contribute to Global Polio Eradication With its Innovative Vaccine Picovax
Press release submission | Jun 27, 2019

CHILDREN'S NATIONAL HEALTH SYSTEM: Children's National study identifies potential pupillary biomarker for pediatric bowel and bladder dysfunction (BBD) that could improve diagnosis and intervention
Press release submission | Jun 21, 2019

FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH: New research provides insight into immunity of lupus patients
Press release submission | Jun 20, 2019

SUMMIT MEDICAL GROUP: CityMD and Summit Medical Group Announce Plans to Merge to Deliver an Unparalleled Patient Care Experience
Press release submission | Jun 14, 2019

JOHNSON & JOHNSON: Janssen reports top-line Phase 3 results for TREMFYA® (guselkumab) in adults with active psoriatic arthritis
Press release submission | Jun 14, 2019

BERGENBIO ASA: BerGenBio Presents Preliminary Phase II Clinical Data at EHA 24: Bemcentinib in Combination With Low Dose Chemotherapy Yields Durable Responses in AML Patients Unfit for Intensive Chemotherapy
Press release submission | Jun 7, 2019

AMERICAN COLLEGE OF CARDIOLOGY: Veradigm Partner to Accelerate Heart Disease, Diabetes Patient Treatment

Trending
Patient Daily | Jul 8, 2025

Clinical assistant professor at Stanford: ‘Musical background is associated with better performance of fundamental surgical skills'
+ Pharmaceuticals
Patient Daily | Jul 10, 2025

PhRMA Executive VP: ‘State policymakers can lead the way and must address 340B abuse and protect patients from PBMs'
+ Pharmaceuticals
Patient Daily | Jul 8, 2025

Psychedelic mushrooms' compound shows potential antiaging effects
Patient Daily | Jul 9, 2025

FDA approves Longeveron's Phase 2 study for pediatric dilated cardiomyopathy treatment